All In Biotech

Drug Trial Radar · NCT04431778

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

Last checked: Nov 20, 2026Latest source record: Jan 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

64

Planned (sponsor's estimate)

Start

Nov 1, 2020

Primary completion

Nov 30, 2023

Study completion Dec 31, 2023

Sponsor

Lead sponsor
University Hospital, Clermont-FerrandAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the efficacy and tolerance of low doses of ethosuximide in the treatment of peripheral neuropathic pain

Conditions

  • Peripheral Neuropathic Pain

Interventions

  • EthosuximideDrug

    Taking the treatment (1 daily intake during the evening meal) according to increasing dosage: Step 1: 2.5 ml (125 mg) / day for 7 days Step 2: 5 ml (250 mg) / day for 7 days Step 3: 7.5 ml (375 mg) / day for 7 days Step 4 (final): 10 ml (500 mg) / day for the remainder of the study (12 weeks).

  • PlaceboDrug

    Taking the treatment (1 daily intake during the evening meal) according to increasing dosage: Step 1: 2.5 ml (125 mg) / day for 7 days Step 2: 5 ml (250 mg) / day for 7 days Step 3: 7.5 ml (375 mg) / day for 7 days Step 4 (final): 10 ml (500 mg) / day for the remainder of the study (12 weeks).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Neuropathic pain intensityTime frame: Day 0
  2. Neuropathic pain intensityTime frame: Day 84

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Uniervity hospital, Amiens

    Amiens, France · Not yet recruiting

  • Hospital of Annecy Genevois

    Annecy, France · Not yet recruiting

  • University hospital, clermont ferrand

    Clermont-Ferrand, France · Recruiting

  • CIC, Hospital University, Clermont Ferrand

    Clermont-Ferrand, France · Not yet recruiting

  • University Hospital, Grenoble

    Grenoble, France · Not yet recruiting

  • CHu Limoges

    Limoges, France · Not yet recruiting

  • Hospital University, Lyon

    Lyon, France · Not yet recruiting

  • University Hospital, Saint Etienne

    Saint-Etienne, France · Not yet recruiting

  • Hospital of Valence

    Valence, France · Not yet recruiting

  • Hospital of Voiron

    Voiron, France · Not yet recruiting

  • University Hospital Lyon sud - Pierre Bénite

    Lyon, AURA, France · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.